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Information in practice
Effect of diverging policy across the NHS
Arturo Alvarez-Rosete, Gwyn Bevan, Nicholas Mays, Jennifer Dixon
Since 1948 the NHS has provided universal coverage
that is free at the point of use, funded largely from
taxation. Reforms have come and gone, but until the
late 1990s they had been applied similarly across the
four countries of the UK. Although the NHS has never
been homogeneous, in practice the policy differences
between the countries have been marginal compared
with the similarities. However, in 1998 the Labour gov-
ernment devolved power to an elected parliament in
Scotland, an elected assembly in Wales, and, until it was
suspended in 2002, an elected assembly in Northern
Ireland.
Although the powers of each political body differ,
each has important freedoms with respect to NHS
policy. As a result, in England, the emphasis has been
on national targets to improve performance (particu-
larly reducing waiting times), increasing capacity, and
sharper market-style incentives. In Scotland, the 1990s
quasi-market has been abolished and steps taken to
build a professionally led, integrated system based on
concepts such as managed clinical networks. In Wales,
the focus has been on improving the public health
through partnership working between the local NHS,
local government, and communities, and in Northern
Ireland, developments have been stalled by political
uncertainty.1 2 What is the effect of these differences in
emphasis of policy?
Methods
We used routine data on performance of the NHS in
each country to compare health indicators for 2002-3
with those in 1996-7 (before devolution). The baseline
data were from a previous study by one of the authors.3
We present six sets of indicators relating to health, per
capita expenditure, inputs (such as staff and beds),
activity (such as inpatient and day case rates), rates of
selected operations, and other outputs (such as waiting
times).
After collecting the data, we tried to contact people
with overall responsibility for health statistics in each
country and have successfully confirmed the accuracy
of the data we have used for Northern Ireland,
Scotland, and Wales. There seems to be no one who
can do this for England. The detailed definitions of
each of the indicators, their sources, and discrepancies
between the data are given on the King’s Fund website
(www.kingsfund.org.uk/document.rm?id = 5793).
Health indicators
Table 1 shows that life expectancy has risen in all four
countries and for both sexes during 1996-2002. The
gain in life expectancy has been roughly a year,
although the increase is likely to be attributable as
much to rising living standards and better conditions
in early life as to the actions of the NHS and mirrors
trends in many countries in the Organisation for Eco-
nomic Cooperation and Development.4
The all cause standardised mortality ratio indicates
only slight signs of convergence between the four
countries as life expectancy has lengthened, with Scot-
land having the highest ratio. In infant mortality, the
trend in the early 1990s of declining rates in the UK5
has continued in all four countries. Likewise, perinatal
mortality has fallen in all countries except Wales.
The prevalence of self-reported illness and
restricted activity among people living in the
community from sample surveys shows no trend either
over the study period or between the four countries.
The proportion of the population self-reporting illness
has tended to rise decade on decade since the 1970s,
though the increase has slowed since the 1980s.6 The
Scots report lower rates of longstanding and limiting
longstanding illness than the English. We have found
no evidence to explain this, but it may be because more
Scots die prematurely and so do not survive to experi-
ence limiting chronic conditions.
Expenditure and other inputs
England has had the lowest spending per capita in
each year and Scotland the highest (table 2). Although
each country introduced formulas to guide the alloca-
tion of resources to achieve equitable spending per
capita in the late 1970s, no such policy has been
applied between the countries of the UK.7 8 Over the
six years from 1996, per capita spending has increased
by 30% in England, 28% in Northern Ireland, 22% in
Wales, and 20% in Scotland. These crude statistics do
not take account of differences between countries in
need for health care arising from age or morbidity. If
allocations of resources for each country were based
on the size of populations weighted by standardised
mortality ratios (but not adjusted for differences in age
structures), then Scotland would have 20% higher
expenditure per capita than England rather than the
current 16%.
We found it difficult to find a common source for
what ought to be basic information. Dixon and
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colleagues were able to report not only per capita
spending on the NHS but also details of expenditure
on hospital and community health services, family
health services, and personal social services.3 We have
been unable to find information in a form that will
allow us to derive these elements on a consistent and
credible basis.
The number of hospital beds per 1000 population
has fallen in all four countries and particularly in Scot-
land and Northern Ireland, which had the most beds in
1996 (table 3). However, England still only has just over
half the number of beds per 1000 population as Scot-
land. Most of the bed losses seem to have been in the
long stay or non-acute sector, and the availability of
acute beds has risen in all countries. As a result, the
NHS is increasingly providing an acute service, as
shown by the rising proportion of day and outpatient
treatment (see below).
All four countries have had increases in medical
and dental staff during the study period (table 3). Scot-
land and Northern Ireland started with the highest
number of staff per 1000 population, and although
England has gained staff per capita, its position relative
to Scotland has scarcely altered. The number per
capita of nursing, health visiting, and midwifery staff
has risen by 0.5% in England, Scotland, and Wales and
by 0.1% in Northern Ireland. Scotland still has the
most nurses per capita.
Activity
Table 4 shows that bed occupancy rose between 1996
and 2002 in all four countries and is now over 80%.
Rates of outpatient appointments/1000 population
have risen in all four countries, notably in Wales and
England, although in all countries the ratio of new to
follow-up appointments was similar. Rates of proce-
dures carried out as day cases have also risen in all
countries except for Wales, where, puzzlingly, the rate
seems to have dropped by over half between 1996 and
2002. The rate of inpatient admissions rose slightly in
Northern Ireland, stayed roughly the same in Scotland,
but dropped slightly in England and Wales, possibly as
a result of a slight reduction in beds. The increases in
the NHS workforce over this period have been accom-
panied by falls in crude rates of productivity as
measured by outpatient appointments and inpatient
admissions per medical or dental staff member and per
nurse.
Operation rates
Operation rates for selected common procedures have
increased in all four countries (table 5). An exception
to this is varicose vein surgery, for which rates dropped
everywhere except Northern Ireland. Given the
constraints on the supply of surgery, it may be that
greater priority has been given to other procedures (as
varicose vein surgery has a larger discretionary
element than other procedures), treatment has been by
injections (which would not be recorded as this is an
outpatient procedure), or greater numbers of patients
were seeking care outside the NHS.
The biggest rise was in operations for cataracts
(extracapsular extraction of lens and prosthesis of
lens), especially in England. Despite the high numbers
Table 1 Health indicators for UK countries
Indicator
England Scotland Wales Northern Ireland
1996-7 2002-3 1996-7 2002-3 1996-7 2002-3 1996-7 2002-3
Standardised mortality ratio:
Men 98 98 119 119 102 102 109 102
Women 98 98 116 113 102 104 108 102
Life expectancy (years):
Men 74.5 76.2 72.2 73.5 73.9 75.6 73.8 75.6
Women 79.6 80.7 77.9 78.9 79.1 80.2 79.2 80.4
Perinatal mortality/1000 8.7 8.3 9.2 7.6 7.5 7.7 9.4 8.9
Infant mortality/1000 6.1 5.2 6.2 5.3 5.6 4.5 5.8 4.7
Proportion reporting illness (%):
Longstanding illness 35 35 33 31 38 38 34 36
Limiting longstanding illness 22 21 21 18 26 24 25 26
Table 2 Total NHS expenditure per capita by country
Expenditure per capita (£)
1996-7 2002-3
England 831 1085
Scotland 1047 1262
Wales 968 1186
Northern Ireland 944 1214
Table 3 Availability of hospital beds and health staff in UK countries
Input
England Scotland Wales Northern Ireland
1996-7 2002-3 1996-7 2002-3 1996-7 2002-3 1996-7 2002-3
Hospital beds/1000 population
(all specialties)
4.1 3.8 7.7 6 5.3 5 5.7 4.9
Hospital beds in acute
specialties (% of total beds)
76.2 79.4 68.2 72.1 78.1 81.4 71.2 73.5
Staff/1000 population:
Medical and dental* 1.1 1.4 1.5 1.8 1.2 1.4 1.3 1.6
Nursing, midwifery, and
health visiting*
5 5.6 6.9 7.4 5.9 6.4 6.9 7
General practitioners† 0.56 0.57 0.72 0.76 0.6 0.61 0.62 0.63
*Whole time equivalent.
†Unrestricted principals.
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of people waiting for hip replacement, the increase in
operation rates was modest in Wales, Scotland, and
Northern Ireland, although it was proportionately
higher in England. Overall, the data show a slightly
higher increase in operation rates in England than in
other countries.
Waiting times and satisfaction with
services
England,Wales, and Northern Ireland publish statistics
for people on waiting lists for an elective admission (as
an inpatient or day case) or first outpatient
appointment in a broadly comparable form. In
Scotland, however, the Information and Statistics Divi-
sion publishes statistics that largely focus on waiting
times for patients who have been treated, and Dixon
has shown that using this different data source gives
different results.9 We therefore have not reported wait-
ing times for Scotland in table 6.
Before April 2003, Scotland had two waiting lists: a
true waiting list and a deferred waiting list for patients
who had been unavailable for admission for a time for
medical or social reasons or had not attended on an
offered admission date.10 Patients on the deferred wait-
ing list were not covered by national waiting time guar-
antees. Data were collected on waiting times for
patients on the true waiting list only. At the end of
March 2003, only one patient with a guarantee on the
true waiting list for elective admission had been waiting
more than 12 months. The statistics on patients
treated, which include patients from both types of wait-
ing lists (including patients without a waiting time
guarantee), show that more than 7000 elective patients
treated the following year had waited more than 12
months.
Table 4 Comparison of NHS activity in UK countries
England Scotland Wales Northern Ireland
1996-7 2002-3 1996-7 2002-3 1996-7 2002-3 1996-7 2002-3
Bed occupancy (%) 81.3 85.4 80.6 81.4 78.3 82.5 78.9 84.3
General practitioner
consultations per person
5 4 6 4 5 5 NA* NA*
Outpatient activity
Total appointments/1000
population
842.6 899.8 927.1 931.1 888.7 972.3 852 861.8
New appointments/1000
population
232.5 262.7 256.8 260.7 230.7 252.2 234.4 240.2
Ratio of new to return
appointments
2.62 2.43 2.61 2.57 2.85 2.86 2.63 2.59
Inpatient and day case
activity
Day cases/1000 population 61 75 75.4 83.1 99 45.6 58.8 81.7
Inpatient admissions/1000
population
171 157 189 188 177 174 180.4 192.6
Crude productivity (No of
events/staff member)
Outpatient appointment:
Doctors and dentists 766.0 642.7 618.1 517.3 740.6 694.5 655.4 538.6
Nurses, midwives, and
health visitors
168.5 160.7 134.4 125.8 150.6 151.9 121.9 122.6
Hospital admissions:
Doctors and dentists 155.5 112.1 126.0 104.4 147.5 124.3 138.8 120.4
Nurses, midwives, and
health visitors
34.2 28.0 27.4 25.4 30.0 27.2 25.8 27.4
*NA=Not available= Data not recorded
Table 5 Comparison of NHS operation rates per 10 000 population for selected procedures in UK countries
Procedure (OPCS4
classification*)
England Scotland Wales Northern Ireland
1996-7 2002-3 1996-7 2002-3 1996-7 2002-3 1996-7 2002-3
Extracapsular extraction of
lens (C71)
NA† 54.2 31.1 40.2 31.6 55.3 29.6 39.3
Prosthesis of lens (C75) 28.7 54.6 31.7 40.6 39.2 57.1 30 39.5
Excision of gall bladder
(J18)
7.1 9.4 10.5 11.7 10.5 11 9.9 12.8
Inguinal hernia (T20) 16.8 16.7 12.5 11.1 14.1 14.6 10.4 12
Total prosthetic
replacement of knee joint
(W40-W42)
5 8.5 4.9 6.9 5.9 8.6 3.9 4.1
Varicose vein operation
(L85-L87)
11.2 9.4 26 24.9 17.9 12 11.8 12.7
Hip replacement
(W37-W39)
6.9 8.7 9.2 9.9 9.4 9.4 8.9 8.7
Coronary artery bypass
grafting (K40-K46)
4.7 5.1 8.6 9.8 4.2 7.7 5.4 3.2
*Office of Population Censuses and Surveys classification of surgical operations and procedures, 4th revision.
†Data not available free of charge.
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For the other UK countries the most striking
divergence is in the times people have to wait for a first
outpatient appointment and an elective admission
(table 6). Policies in England have been directed at
reducing these waiting times by setting and imple-
menting quantitative, time specific targets, with strong
performance management and sanctions for failure.13
Between 1996 and 2002, performance in England
improved across all measures of waiting times for
inpatients and day cases: the total percentage of the
population waiting reduced, and the proportion wait-
ing less than six months for an elective admission
increased to 80%. In the other countries, these
statistics worsened.
In 2002, England had the lowest percentage of the
population waiting and virtually no one had to wait
more than six months for a first outpatient
appointment or more than 12 months for an elective
admission. In contrast, in Wales and Northern Ireland
around a third of patients were waiting longer than six
months for an outpatient appointment and the
proportion waiting more than 12 months for
admission was 16% and 22%.
Table 6 shows public satisfaction with various
aspects of the NHS. The survey in Northern Ireland11
asked slightly different questions from the survey in the
other three countries,12 and the statistics may not be
comparable. Satisfaction decreased across all reported
measures in Wales, particularly for outpatient and gen-
eral practitioner care, and increased in Northern
Ireland, where satisfaction was extraordinarily high.
The reported measures of satisfaction for both
England and Scotland showed increases for the
general running of the NHS, decreases for general
practitioner care, and marginal changes for inpatient
and outpatient care.
Effects of divergence
We used a small number of indicators to compare the
NHS in 2002 with 1996. Although we tried to make
the indicators comparable, some of the definitions
used in each country differ. The quality of data may
vary too. Nevertheless, the indicators provide a useful
description of the systems, albeit at a very aggregate
level, and this analysis has identified some important
trends.
The data do not suggest that the UK countries with
higher levels of real healthcare resources or expendi-
ture have more activity, better population health, or
higher levels of public satisfaction. Hence these
outcomes may be more dependent on how resources
are deployed and how factors outside the healthcare
system influence health.
Despite the extra finance to the NHS over the
period, the numbers of healthcare staff per 1000
population rose only modestly. Rates of operations for
which people commonly wait have all risen, particu-
larly in England, although the rise in England is
smaller than might be expected given the investment
made and the political and managerial priority given
to reducing waiting.
The most striking differences between 1996 and
2002 are in the reported reductions in waiting in Eng-
land, which seem to be the result of strong
performance management against targets. Policies of
other countries may take a longer time to show
benefits or have made greater headway on indicators
not selected here. The thorough study by Leatherman
and Sutherland that developed and reported indica-
tors of quality using routinely collected data found only
six indicators for comparing effectiveness across the
four UK countries.14 They showed that (for 2002, unless
otherwise indicated): Scotland had the highest rates of
breast screening coverage of women aged 50-64, influ-
enza vaccination for the over 65s (2004), and MMR
vaccination coverage of 2 year olds (2001); England
had the lowest mortality from colorectal cancer and
coronary heart disease; and Wales had the highest
rates of statin prescribing.
We have been astonished at the difficulty, and in
some cases impossibility, of obtaining valid comparable
basic statistics on the NHS in the four countries. Devo-
lution has resulted in natural experiments of divergent
policies across these countries, with huge and increas-
ing sums of public money spent on both health care
and new computerised systems for collecting data. The
new general practice contract ought, through the
Table 6 Comparison of waiting times and satisfaction in UK countries
England Scotland Wales Northern Ireland
1996-7 2002-3 1996-7 2002-3 1996-7 2002-3 1996-7 2002-3
Inpatient and day case waiting
list (%):
Total population waiting* 2.3 1.9 NA NA 2.2 2.5 2.7 3.3
Waiting <6 months† 74.9 80.6 NA NA NA 63 62.2 60.1
Waiting 6 to <12 months† 22.4 19.4 NA NA NA 21 20.6 18.4
Waiting ≥12 months† 2.7 0 NA NA 9.9 15.9 17.1 22.0
Outpatient waiting list (%):
Total population waiting* NA NA NA NA 3.5 7.4 3.7 8.4
Waiting <3 months† NA 80 NA NA 72 45.7 64.8 42.1
Waiting <6 months† NA 100 NA NA 94.1 67.6 80.7 61.4
Waiting ≥6 months† NA 0 NA NA 5.9 32.4 19.3 38.6
% of public satisfied11 12:
With general running of NHS 36 43 37 40 41 38 48 74
With inpatient care 51 49 61 58 63 60 67 84
With outpatient care 50 51 64 60 63 55 70 88
With general practice care 77 72 81 73 79 68 83 90
NA=Data not available or not recorded in a comparable format.
*Number on waiting list as % of total population.
†% of those on the waiting list.
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quality and outcomes framework, to generate data that
will enable evaluation of the same policy throughout
the UK.15 But, without careful design, differences in
other policies in each country will be reflected in
differences in the data collected, which will nullify
attempts at effective scrutiny and learning.
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Summary points
Since devolution in 1998, it has become more
difficult to collect comparable data across the four
UK countries, particularly on NHS expenditure
and waiting times
NHS activity and health outcomes seem more
dependent on how healthcare resources are
deployed than higher levels of resources
The most striking difference between the
countries in 2002 was the shorter waiting times in
England, which introduced enforced targets for
waiting
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If at first you don’t succeed . . . sue
In times past if you failed an exam at medical school you had a
“long dark tea time of the soul.” You asked yourself why you spent
all that time in the college bar, the snooker hall, or in classical
civilisation lectures. You vowed not to leave it all to the last minute
for the repeats. But these days—in the United States at least—if
you don’t succeed you can always sue.
Firstly, you and your lawyers can look at the validity of the
exam. If you pass the exam does that mean that that you’re ready
to work as a doctor? If you fail does that mean that you’re not
ready? If the answer to either of these questions is no then you
may have a case. For example, if many of the questions in the
final medical exam test knowledge of basic sciences then the
exam may not be a valid test. A doctor may not know the ins and
outs of the Krebs cycle, but he or she may still be able to give
sensible and evidence based dietary advice to patients. And what
about reliability? Test-retest reliability is a good place to start.
How many students who passed their final exams in May would
still pass them if they were taken again in September? If large
numbers of your students would fail in September, then your
exam is not reliable and your students are probably crammers.
So if you are setting an exam, how do you avoid these pitfalls?
Firstly, make sure that the exam tests what it’s supposed to test. If
it is a test of whether candidates would make good general
physicians then ensure that the questions deal with common
medical problems that would be seen on an average take. So most
of the questions should be on chronic bronchitis rather than
porphyria, and they should test candidates’ knowledge of the
diagnosis and treatment of chronic bronchitis rather than its
pathophysiology or epidemiology. And if you want to stop the
crammers concentrate on continual assessment rather than a
single high-stakes exam at the end. It is strange that some people
are calling for doctors to do an exam to stay on the medical
register when universities are increasingly realising that the best
way of deciding who should get on the register is by regular
assessment.
At BMJ Learning we offer formative assessment; it doesn’t
count towards an exam or a degree, and you can repeat the
modules as often as you like. One of our most recent modules is
on the diagnosis and treatment of common skin tumours in
primary care. It is weak on paraneoplastic pemphigus but strong
on basal cell carcinoma and squamous cell carcinoma and
malignant melanoma. There is little hard evidence on the
effectiveness or otherwise of online learning in medicine, but one
of the few areas where online learning has been shown to be
effective is in dermatology and more specifically in the early
detection of skin cancer.1 You are welcome to have a look at our
module on www.bmjlearning.com.
Kieran Walsh clinical editor, BMJ Learning
(bmjlearning@bmjgroup.com)
1 Harris JM Jr, Salasche SJ, Harris RB. Can internet-based continuing medical
education improve physicians’ skin cancer knowledge and skills? J Gen Intern
Med 2001;16:50-6.
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